분자세포유전학 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 용도별, 기술별, 제품별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Technology, By Product, By End use, By Region and Competition, 2020-2030F
상품코드:1881474
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 분자세포유전학 시장은 2024년에 22억 4,000만 달러로 평가되었으며, 2030년까지 CAGR 8.33%로 성장하여 36억 2,000만 달러에 달할 것으로 예측됩니다.
분자세포유전학은 분자생물학과 세포유전학을 통합하여 주로 유전성 질환 및 암과 관련된 이상을 검출하기 위해 염색체 구조를 분석합니다. 이 시장의 확대는 기본적으로 정밀한 진단 도구를 필요로 하는 유전성 및 종양성 질환의 전 세계 유병률 증가에 의해 촉진되고 있습니다. 또한, 맞춤형 의료에 대한 수요 증가도 시장 성장을 크게 견인하고 있습니다. 개인맞춤의료는 상세한 유전체 지식을 바탕으로 치료법을 맞춤화하는 것입니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
22억 4,000만 달러
시장 규모 : 2030년
36억 2,000만 달러
CAGR : 2025-2030년
8.33%
가장 빠르게 성장하는 부문
종양학
최대 시장
북미
주요 시장 촉진요인
세계 분자세포유전학 시장은 전 세계적으로 증가하는 암 및 유전성 질환의 발생률에 큰 영향을 받고 있습니다. 이러한 광범위한 건강 문제는 매우 정밀하고 종합적인 진단 도구를 필요로 하며, 염색체 이상과 유전적 변이를 검출할 수 있는 분자 세포 유전학 기술에 대한 수요를 직접적으로 촉진하고 있습니다.
주요 시장 과제
첨단 분자세포유전학 장비의 높은 비용과 복잡한 검사 절차에 필요한 전문 지식은 시장 확대에 큰 장벽으로 작용하고 있습니다. 이러한 재정적 부담은 특히 의료 인프라가 아직 개발 중인 지역에서는 막대한 초기 투자 및 지속적인 운영 비용으로 인해 이러한 첨단 진단 도구의 보급을 제한하고 있습니다.
주요 시장 동향
인공지능(AI)과 자동화의 통합은 효율성과 정확성을 향상시키고 세포유전학 워크플로우를 근본적으로 변화시키고 있습니다. 이러한 첨단 시스템은 이미지 분석, 핵형 분석, 염색체 이상 검출과 같은 노동 집약적인 프로세스를 간소화하도록 설계되어 인위적인 오류 발생률을 줄이고 검사 결과 보고 시간을 단축합니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 분자세포유전학 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
용도별(유전성 질환, 종양학, 맞춤형 의료, 기타)
기술별(비교 유전체 하이브리다이제이션, FISH, 면역조직화학, 핵형 분석)
제품별(기기, 소모품, 소프트웨어·서비스)
최종사용자별(병원·클리닉, 학술연구기관, 제약·바이오테크놀러지 기업, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 분자세포유전학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 분자세포유전학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 분자세포유전학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 분자세포유전학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 분자세포유전학 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 분자세포유전학 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Danaher Corporation
MetaSystems International
Agilent Technologies, Inc.
Abbott Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Oxford Gene Technology IP Limited
F. Hoffmann-La Roche Ltd
PerkinElmer Inc.
BIOVIEW Ltd.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Molecular Cytogenetics Market, valued at USD 2.24 Billion in 2024, is projected to experience a CAGR of 8.33% to reach USD 3.62 Billion by 2030. Molecular cytogenetics integrates molecular biology and cytogenetics to analyze chromosome structure, primarily for detecting abnormalities linked to genetic disorders and cancer. This market's expansion is fundamentally driven by the increasing global prevalence of genetic conditions and oncological diseases, necessitating precise diagnostic tools. The growing demand for personalized medicine, which relies on detailed genomic insights for tailored therapies, also significantly propels market growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.24 Billion
Market Size 2030
USD 3.62 Billion
CAGR 2025-2030
8.33%
Fastest Growing Segment
Oncology
Largest Market
North America
Key Market Drivers
The global molecular cytogenetics market is significantly influenced by the escalating incidence of cancer and genetic disorders worldwide. These pervasive health challenges necessitate highly precise and comprehensive diagnostic tools, directly driving the demand for molecular cytogenetic techniques capable of detecting chromosomal abnormalities and genetic variations. Such advanced diagnostic capabilities are crucial for early detection, accurate prognosis, and effective treatment planning in oncology and inherited conditions.
Key Market Challenges
The high cost of advanced molecular cytogenetics instrumentation and the specialized expertise required for complex testing procedures represent a significant barrier to market expansion. This financial burden restricts the widespread adoption of these sophisticated diagnostic tools, particularly in regions with developing healthcare infrastructures that face challenges with substantial upfront capital investments and ongoing operational expenses. Acquiring and maintaining state-of-the-art equipment, alongside recruiting and retaining highly skilled personnel, places considerable strain on laboratory budgets.
Key Market Trends
The increasing integration of Artificial Intelligence and automation is fundamentally transforming cytogenetic workflows by enhancing efficiency and precision. These advanced systems are designed to streamline labor-intensive processes such as image analysis, karyotyping, and the detection of chromosomal abnormalities, thereby reducing manual error rates and accelerating turnaround times. For instance, according to CAP Today, in December 2024, digital pathology, which encompasses AI and automation in image analysis, reflected approximately 10 percent adoption in clinical laboratories, indicating a gradual but steady integration into diagnostic practices.
Key Market Players
Danaher Corporation
MetaSystems International
Agilent Technologies, Inc.
Abbott Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Oxford Gene Technology IP Limited
F. Hoffmann-La Roche Ltd
PerkinElmer Inc.
BIOVIEW Ltd.
Report Scope:
In this report, the Global Molecular Cytogenetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Molecular Cytogenetics Market, By Application:
Genetic Disorders
Oncology
Personalized Medicine
Others
Molecular Cytogenetics Market, By Technology:
Comparative Genomic Hybridization
FISH
Immunohistochemistry Karyotyping
Molecular Cytogenetics Market, By Product:
Instruments
Consumables
Software & Services
Molecular Cytogenetics Market, By End use:
Hospitals & Clinics
Academic Research Institutes
Pharmaceutical & Biotech Companies
Others
Molecular Cytogenetics Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Molecular Cytogenetics Market.
Available Customizations:
Global Molecular Cytogenetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Molecular Cytogenetics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Genetic Disorders, Oncology, Personalized Medicine, Others)
5.2.2. By Technology (Comparative Genomic Hybridization, FISH, Immunohistochemistry Karyotyping)
5.2.3. By Product (Instruments, Consumables, Software & Services)
5.2.4. By End use (Hospitals & Clinics, Academic Research Institutes, Pharmaceutical & Biotech Companies, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Molecular Cytogenetics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Technology
6.2.3. By Product
6.2.4. By End use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Molecular Cytogenetics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Technology
6.3.1.2.3. By Product
6.3.1.2.4. By End use
6.3.2. Canada Molecular Cytogenetics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Technology
6.3.2.2.3. By Product
6.3.2.2.4. By End use
6.3.3. Mexico Molecular Cytogenetics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Technology
6.3.3.2.3. By Product
6.3.3.2.4. By End use
7. Europe Molecular Cytogenetics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Technology
7.2.3. By Product
7.2.4. By End use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Molecular Cytogenetics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Technology
7.3.1.2.3. By Product
7.3.1.2.4. By End use
7.3.2. France Molecular Cytogenetics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Technology
7.3.2.2.3. By Product
7.3.2.2.4. By End use
7.3.3. United Kingdom Molecular Cytogenetics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Technology
7.3.3.2.3. By Product
7.3.3.2.4. By End use
7.3.4. Italy Molecular Cytogenetics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Technology
7.3.4.2.3. By Product
7.3.4.2.4. By End use
7.3.5. Spain Molecular Cytogenetics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Technology
7.3.5.2.3. By Product
7.3.5.2.4. By End use
8. Asia Pacific Molecular Cytogenetics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Technology
8.2.3. By Product
8.2.4. By End use
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Molecular Cytogenetics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Technology
8.3.1.2.3. By Product
8.3.1.2.4. By End use
8.3.2. India Molecular Cytogenetics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Technology
8.3.2.2.3. By Product
8.3.2.2.4. By End use
8.3.3. Japan Molecular Cytogenetics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Technology
8.3.3.2.3. By Product
8.3.3.2.4. By End use
8.3.4. South Korea Molecular Cytogenetics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Technology
8.3.4.2.3. By Product
8.3.4.2.4. By End use
8.3.5. Australia Molecular Cytogenetics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Technology
8.3.5.2.3. By Product
8.3.5.2.4. By End use
9. Middle East & Africa Molecular Cytogenetics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Technology
9.2.3. By Product
9.2.4. By End use
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Molecular Cytogenetics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Technology
9.3.1.2.3. By Product
9.3.1.2.4. By End use
9.3.2. UAE Molecular Cytogenetics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Technology
9.3.2.2.3. By Product
9.3.2.2.4. By End use
9.3.3. South Africa Molecular Cytogenetics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Technology
9.3.3.2.3. By Product
9.3.3.2.4. By End use
10. South America Molecular Cytogenetics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Technology
10.2.3. By Product
10.2.4. By End use
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Molecular Cytogenetics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Technology
10.3.1.2.3. By Product
10.3.1.2.4. By End use
10.3.2. Colombia Molecular Cytogenetics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Technology
10.3.2.2.3. By Product
10.3.2.2.4. By End use
10.3.3. Argentina Molecular Cytogenetics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Technology
10.3.3.2.3. By Product
10.3.3.2.4. By End use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Molecular Cytogenetics Market: SWOT Analysis
